Avalo Therapeutics, Inc. Profile Avatar - Palmy Investing

Avalo Therapeutics, Inc.

Avalo Therapeutics, Inc., a clinical-stage precision medicine company, discovers, develops, and commercializes targeted therapeutics for patients with unmet clinical need in immunology, immuno-oncology, and rare genetic diseases. It develops AVTX-002, a …

Biotechnology
US, Rockville [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Avalo Therapeutics, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Avalo Therapeutics, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Avalo Therapeutics, Inc..

End of AVTX's Analysis
CIK: 1534120 CUSIP: 05338F108 ISIN: US05338F3064 LEI: - UEI: -
Secondary Listings
AVTX has no secondary listings inside our databases.